Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

ClinicalTrials.gov ID: NCT00316849

Public ClinicalTrials.gov record NCT00316849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Study of CCI-779, and Temozolomide in Combination With Radiation Therapy in Glioblastoma Multiforme

Study identification

NCT ID
NCT00316849
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
56 participants

Conditions and interventions

Interventions

  • pharmacological study Other
  • adjuvant therapy Procedure
  • 3-dimensional conformal radiation therapy Radiation
  • intensity-modulated radiation therapy Radiation
  • temsirolimus Drug
  • temozolomide Drug

Other · Procedure · Radiation + 1 more

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2006
Primary completion
Oct 31, 2010
Completion
Not listed
Last update posted
Apr 9, 2013

Started 2006

United States locations

U.S. sites
11
U.S. states
4
U.S. cities
5
Facility City State ZIP Site status
Mayo Clinic in Florida Jacksonville Florida 32224-9980
Medical Oncology and Hematology Associates-West Des Moines Clive Iowa 50325
Mercy Capitol Des Moines Iowa 50307
Iowa Methodist Medical Center Des Moines Iowa 50309
Iowa Oncology Research Association CCOP Des Moines Iowa 50309
Medical Oncology and Hematology Associates-Des Moines Des Moines Iowa 50309
Medical Oncology and Hematology Associates Des Moines Iowa 50314
Mercy Medical Center - Des Moines Des Moines Iowa 50314
Iowa Lutheran Hospital Des Moines Iowa 50316
Mayo Clinic Rochester Minnesota 55905
Altru Cancer Center Grand Forks North Dakota 58201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00316849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 9, 2013 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00316849 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →